These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15237387)

  • 41. Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists.
    Di Stefano A; Sozio P; Cacciatore I; Cocco A; Giorgioni G; Costa B; Montali M; Lucacchini A; Martini C; Spoto G; Di Pietrantonio F; Di Matteo E; Pinnen F
    J Med Chem; 2005 Apr; 48(7):2646-54. PubMed ID: 15801855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
    Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
    Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
    Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands.
    López-Rodríguez ML; Benhamú B; Morcillo MJ; Tejada I; Avila D; Marco I; Schiapparelli L; Frechilla D; Del Río J
    Bioorg Med Chem; 2004 Oct; 12(19):5181-91. PubMed ID: 15351401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
    Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopamine D1/D5 receptor antagonists with improved pharmacokinetics: design, synthesis, and biological evaluation of phenol bioisosteric analogues of benzazepine D1/D5 antagonists.
    Wu WL; Burnett DA; Spring R; Greenlee WJ; Smith M; Favreau L; Fawzi A; Zhang H; Lachowicz JE
    J Med Chem; 2005 Feb; 48(3):680-93. PubMed ID: 15689153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
    Zhang J; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.
    Khalil EM; Ojala WH; Pradhan A; Nair VD; Gleason WB; Mishra RK; Johnson RL
    J Med Chem; 1999 Feb; 42(4):628-37. PubMed ID: 10052970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
    Sipos A; Mueller FK; Lehmann J; Berényi S; Antus S
    Arch Pharm (Weinheim); 2009 Oct; 342(10):557-68. PubMed ID: 19714675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.
    Ding K; Chen J; Ji M; Wu X; Varady J; Yang CY; Lu Y; Deschamps JR; Levant B; Wang S
    J Med Chem; 2005 May; 48(9):3171-81. PubMed ID: 15857123
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
    Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
    Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
    Bucholtz EC; Brown RL; Tropsha A; Booth RG; Wyrick SD
    J Med Chem; 1999 Aug; 42(16):3041-54. PubMed ID: 10447948
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydantoin-substituted 4,6-dichloroindole-2-carboxylic acids as ligands with high affinity for the glycine binding site of the NMDA receptor.
    Jansen M; Potschka H; Brandt C; Löscher W; Dannhardt G
    J Med Chem; 2003 Jan; 46(1):64-73. PubMed ID: 12502360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular electrostatic potential of D1 and D2 dopamine agonists.
    Alkorta I; Villar HO
    J Med Chem; 1994 Jan; 37(1):210-3. PubMed ID: 7904647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
    Tagmatarchis N; Thermos K; Katerinopoulos HE
    J Med Chem; 1998 Oct; 41(21):4165-70. PubMed ID: 9767652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.
    Vivo M; Lin H; Strange PG
    Mol Pharmacol; 2006 Jan; 69(1):226-35. PubMed ID: 16204468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.
    Liu Z; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Jul; 16(14):6675-81. PubMed ID: 18562201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.